Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model
Bone-marrow transplantation (BMT) can repopulate the liver through BM-derived hepatocyte (BMDH) generation, although the underlying mechanism remains unclear. Using fumarylacetoacetate hydrolase–deficient ( Fah −/− ) mice as a liver-failure model, we confirmed that BMDHs were generated by fusion of...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2015-09, Vol.5 (1), p.13687, Article 13687 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Bone-marrow transplantation (BMT) can repopulate the liver through BM-derived hepatocyte (BMDH) generation, although the underlying mechanism remains unclear. Using fumarylacetoacetate hydrolase–deficient (
Fah
−/−
) mice as a liver-failure model, we confirmed that BMDHs were generated by fusion of BM-derived CD11b
+
F4/80
+
myelomonocytes with resident
Fah
−/−
hepatocytes. Hepatic NK cells became activated during BMDH generation and were the major IFN-γ producers. Indeed, both NK cells and IFN-γ were required for BMDH generation since WT, but not NK-, IFN-γ–, or IFN-γR1–deficient BM transplantation successfully generated BMDHs and rescued survival in
Fah
−/−
hosts. BM-derived myelomonocytes were determined to be the IFN-γ–responding cells. The IFN-γ–IFN-γR interaction contributed to the myelomonocyte–hepatocyte fusion process, as most of the CD11b
+
BMDHs in mixed BM chimeric
Fah
−/−
hosts transplanted with a 1:1 ratio of CD45.1
+
WT and CD45.2
+
Ifngr1
−/−
BM cells were of CD45.1
+
WT origin. Confirming these findings
in vitro
, IFN-γ dose-dependently promoted the fusion of GFP
+
myelomonocytes with
Fah
−/−
hepatocytes due to a direct effect on myelomonocytes; similar results were observed using activated NK cells. In conclusion, BMDH generation requires NK cells to facilitate myelomonocyte–hepatocyte fusion in an IFN-γ–dependent manner, providing new insights for treating severe liver failure. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep13687 |